Pharmacological Reviews
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     


0031-6997/03/5504-597-606$7.00
Pharmacol Rev 55:597-606, 2003

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Neubig, R. R.
Right arrow Articles by Christopoulos, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Neubig, R. R.
Right arrow Articles by Christopoulos, A.

International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on Terms and Symbols in Quantitative Pharmacology

Richard R. Neubig, Michael Spedding, Terry Kenakin and Arthur Christopoulos

Department of Pharmacology, University of Michigan, Ann Arbor, Michigan (R.R.N.); Institute de Recherches Internationales Servier, Neuilly sur Seine, France (M.S.); Systems Research, GlaxoSmithKline Research and Development, Research Triangle Park, North Carolina (T.K.); and Department of Pharmacology, University of Melbourne, Parkville, Australia (A.C.)

Abstract
I. Introduction
II. Working Definition of a Receptor
III. Use of Drugs in Definition of Receptors or of Signaling Pathways
    A. The Expression of Amount of Drug: Concentration and Dose
    B. General Terms Used to Describe Drug Action
    C. Experimental Measures of Drug Action
    D. Terms and Procedures Used in the Analysis of Drug Action
IV. Appendix
    A. Microscopic and Macroscopic Equilibrium Constants
    B. Schild Equation and Plot—Further Detail
    C. The Relationship between the Hill and Logistic Equation
The recommendations that follow have been updated from the proposals of a Technical Subcommittee set up by the International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification (Jenkinson DH, Barnard EA, Hoyer D, Humphrey PPA, Leff P, and Shankley NP (1995) International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. IX. Recommendations on terms and symbols in quantitative pharmacology. Pharmacol Rev 47:255–266).

Address correspondence to: Richard R. Neubig, Department of Pharmacology, 1301 MSRB III/Box 0632, University of Michigan, Ann Arbor, MI 48109-0632. E-mail: RNeubig{at}umich.edu




This article has been cited by other articles:


Home page
 Ann Rheum DisHome page
E Kis, T Nagy, M Jani, E Molnar, J Janossy, O Ujhellyi, K Nemet, K Heredi-Szabo, and P Krajcsi
Leflunomide and its metabolite A771726 are high affinity substrates of BCRP: implications for drug resistance
Ann Rheum Dis, July 1, 2009; 68(7): 1201 - 1207.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
V. Camarda, A. Rizzi, C. Ruzza, S. Zucchini, G. Marzola, E. Marzola, R. Guerrini, S. Salvadori, R. K. Reinscheid, D. Regoli, et al.
In Vitro and in Vivo Pharmacological Characterization of the Neuropeptide S Receptor Antagonist [D-Cys(tBu)5]Neuropeptide S
J. Pharmacol. Exp. Ther., February 1, 2009; 328(2): 549 - 555.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
B. Holst, T. M. Frimurer, J. Mokrosinski, T. Halkjaer, K. B. Cullberg, C. R. Underwood, and T. W. Schwartz
Overlapping Binding Site for the Endogenous Agonist, Small-Molecule Agonists, and Ago-allosteric Modulators on the Ghrelin Receptor
Mol. Pharmacol., January 1, 2009; 75(1): 44 - 59.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
A. J. Harmar, R. A. Hills, E. M. Rosser, M. Jones, O. P. Buneman, D. R. Dunbar, S. D. Greenhill, V. A. Hale, J. L. Sharman, T. I. Bonner, et al.
IUPHAR-DB: the IUPHAR database of G protein-coupled receptors and ion channels
Nucleic Acids Res., January 1, 2009; 37(suppl_1): D680 - D685.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
D. J. Nicholls, N. P. Tomkinson, K. E. Wiley, A. Brammall, L. Bowers, C. Grahames, A. Gaw, P. Meghani, P. Shelton, T. J. Wright, et al.
Identification of a Putative Intracellular Allosteric Antagonist Binding-Site in the CXC Chemokine Receptors 1 and 2
Mol. Pharmacol., November 1, 2008; 74(5): 1193 - 1202.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
P. C. Jensen, S. Thiele, T. Ulven, T. W. Schwartz, and M. M. Rosenkilde
Positive Versus Negative Modulation of Different Endogenous Chemokines for CC-chemokine Receptor 1 by Small Molecule Agonists through Allosteric Versus Orthosteric Binding
J. Biol. Chem., August 22, 2008; 283(34): 23121 - 23128.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
B. Roy, E. J. Halvey, and J. Garthwaite
An Enzyme-linked Receptor Mechanism for Nitric Oxide-activated Guanylyl Cyclase
J. Biol. Chem., July 4, 2008; 283(27): 18841 - 18851.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
J.-P. Rospars, P. Lansky, M. Chaput, and P. Duchamp-Viret
Competitive and Noncompetitive Odorant Interactions in the Early Neural Coding of Odorant Mixtures
J. Neurosci., March 5, 2008; 28(10): 2659 - 2666.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
L. M. Ayer, S. M. Wilson, S. L. Traves, D. Proud, and M. A. Giembycz
4,5-Dihydro-1H-imidazol-2-yl)-[4-(4-isopropoxy-benzyl)-phenyl]-amine (RO1138452) Is a Selective, Pseudo-Irreversible Orthosteric Antagonist at the Prostacyclin (IP)-Receptor Expressed by Human Airway Epithelial Cells: IP-Receptor-Mediated Inhibition of CXCL9 and CXCL10 Release
J. Pharmacol. Exp. Ther., February 1, 2008; 324(2): 815 - 826.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
V. A. Avlani, K. J. Gregory, C. J. Morton, M. W. Parker, P. M. Sexton, and A. Christopoulos
Critical Role for the Second Extracellular Loop in the Binding of Both Orthosteric and Allosteric G Protein-coupled Receptor Ligands
J. Biol. Chem., August 31, 2007; 282(35): 25677 - 25686.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
B. Spagnolo, G. Carra, M. Fantin, C. Fischetti, C. Hebbes, J. McDonald, T. A. Barnes, A. Rizzi, C. Trapella, G. Fanton, et al.

J. Pharmacol. Exp. Ther., June 1, 2007; 321(3): 961 - 967.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
A. Pal, D. Mehn, E. Molnar, S. Gedey, P. Meszaros, T. Nagy, H. Glavinas, T. Janaky, O. von Richter, G. Bathori, et al.
Cholesterol Potentiates ABCG2 Activity in a Heterologous Expression System: Improved in Vitro Model to Study Function of Human ABCG2
J. Pharmacol. Exp. Ther., June 1, 2007; 321(3): 1085 - 1094.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
M. M. Rosenkilde, R. David, I. Oerlecke, T. Benned-Jensen, U. Geumann, A. G. Beck-Sickinger, and T. W. Schwartz
Conformational Constraining of Inactive and Active States of a Seven Transmembrane Receptor by Metal Ion Site Engineering in the Extracellular End of Transmembrane Segment V
Mol. Pharmacol., December 1, 2006; 70(6): 1892 - 1901.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. L. Roth, E. Marzola, A. Rizzi, M. Arduin, C. Trapella, C. Corti, R. Vergura, P. Martinelli, S. Salvadori, D. Regoli, et al.
Structure-Activity Studies on Neuropeptide S: IDENTIFICATION OF THE AMINO ACID RESIDUES CRUCIAL FOR RECEPTOR ACTIVATION
J. Biol. Chem., July 28, 2006; 281(30): 20809 - 20816.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
C. P. Fitzsimons, U. A. Gompels, D. Verzijl, H. F. Vischer, C. Mattick, R. Leurs, and M. J. Smit
Chemokine-Directed Trafficking of Receptor Stimulus to Different G Proteins: Selective Inducible and Constitutive Signaling by Human Herpesvirus 6-Encoded Chemokine Receptor U51
Mol. Pharmacol., March 1, 2006; 69(3): 888 - 898.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
M. R. Price, G. L. Baillie, A. Thomas, L. A. Stevenson, M. Easson, R. Goodwin, A. McLean, L. McIntosh, G. Goodwin, G. Walker, et al.
Allosteric Modulation of the Cannabinoid CB1 Receptor
Mol. Pharmacol., November 1, 2005; 68(5): 1484 - 1495.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
R. Corradetti, B. Mlinar, C. Falsini, A. M. Pugliese, A. Cilia, C. Destefani, and R. Testa
Differential Effects of the 5-Hydroxytryptamine (5-HT)1A Receptor Inverse Agonists Rec 27/0224 and Rec 27/0074 on Electrophysiological Responses to 5-HT1A Receptor Activation in Rat Dorsal Raphe Nucleus and Hippocampus in Vitro
J. Pharmacol. Exp. Ther., October 1, 2005; 315(1): 109 - 117.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
J. A. Ballestero, P. V. Plazas, S. Kracun, M. E. Gomez-Casati, J. Taranda, C. V. Rothlin, E. Katz, N. S. Millar, and A. B. Elgoyhen
Effects of Quinine, Quinidine, and Chloroquine on {alpha}9{alpha}10 Nicotinic Cholinergic Receptors
Mol. Pharmacol., September 1, 2005; 68(3): 822 - 829.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
J. Bodenstein, D. P. Venter, and C. B. Brink
Phenoxybenzamine and Benextramine, but Not 4-Diphenylacetoxy-N-[2-chloroethyl]piperidine Hydrochloride, Display Irreversible Noncompetitive Antagonism at G Protein-Coupled Receptors
J. Pharmacol. Exp. Ther., August 1, 2005; 314(2): 891 - 905.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
L. T. May, Y. Lin, P. M. Sexton, and A. Christopoulos
Regulation of M2 Muscarinic Acetylcholine Receptor Expression and Signaling by Prolonged Exposure to Allosteric Modulators
J. Pharmacol. Exp. Ther., January 1, 2005; 312(1): 382 - 390.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition
Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics